Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest income |
45,000
EUR
|
40,000
EUR
|
| Adjustments for dividend income |
-
EUR
|
-
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
4 708
EUR
|
1 031
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
5 521
EUR
|
4 140
EUR
|
| Adjustments for decrease (increase) in biological assets |
11 990
EUR
|
1 529
EUR
|
| Adjustments for amortisation expense |
24,000
EUR
|
16,000
EUR
|
| Adjustments for depreciation expense |
6 443
EUR
|
6 661
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
189,000
EUR
|
202,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
17,000
EUR
|
2,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
-
EUR
|
393,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
8 960
EUR
|
2 701
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
5 880
EUR
|
6 000
EUR
|